 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - RHYTHM PHARMACEUTICALS Inc (RYTM)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-31 Sale | 2020-04-01 4:20 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director | 34,570 | $15.13 | $523,153 | 2,324,893 (Indirect) | View |
| 2020-03-26 Sale | 2020-03-30 4:57 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director | 2,300 | $15.04 | $34,592 | 2,359,463 (Indirect) | View |
| 2020-03-20 Sale | 2020-03-24 4:58 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director | 1,100 | $15 | $16,500 | 2,361,763 (Indirect) | View |
| 2020-03-17 Sale | 2020-03-19 5:04 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director | 30,634 | $15.11 | $463,032 | 2,362,863 (Indirect) | View |
| 2019-12-27 Sale | 2019-12-31 4:02 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer | 35,181 | $22.79 | $801,771 | 29,068 (Direct) | View |
| 2019-12-11 Sale | 2019-12-13 4:25 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director | 17,362 | $25.11 | $435,992 | 2,393,497 (Indirect) | View |
| 2019-12-09 Sale | 2019-12-11 4:13 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director | 64,034 | $25.25 | $1,616,800 | 2,410,859 (Indirect) | View |
| 2019-12-02 Sale | 2019-12-03 8:05 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director | 42,143 | $22.15 | $933,443 | 2,474,893 (Indirect) | View |
| 2019-11-26 Sale | 2019-11-29 2:40 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director | 127,544 | $23.11 | $2,947,317 | 2,517,036 (Indirect) | View |
| 2019-11-22 Sale | 2019-11-26 4:22 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director | 224,025 | $22.53 | $5,047,557 | 2,644,580 (Indirect) | View |
| 2019-11-20 Sale | 2019-11-22 5:30 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director | 206,288 | $21.56 | $4,446,998 | 2,868,605 (Indirect) | View |
| 2019-05-30 Sale | 2019-06-03 4:00 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 10,000 | $25.2 | $252,050 | 42,339 (Direct) | View |
| 2019-05-28 Sale | 2019-05-30 4:01 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 15,000 | $25.42 | $381,350 | 42,339 (Direct) | View |
| 2019-03-15 Sale | 2019-03-19 4:25 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 10,290 | $30.09 | $309,647 | 506,342 (Direct) | View |
| 2019-03-13 Sale | 2019-03-15 4:01 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 9,288 | $30.06 | $279,182 | 516,632 (Direct) | View |
| 2019-02-26 Sale | 2019-02-28 4:01 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 2,449 | $30.04 | $73,571 | 525,617 (Direct) | View |
| 2019-02-15 Sale | 2019-02-20 4:01 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 12,920 | $30.02 | $387,886 | 528,066 (Direct) | View |
| 2019-02-13 Sale | 2019-02-15 4:09 pm | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 3,934 | $30 | $118,020 | 540,986 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-30 Exercise | 2020-03-31 6:00 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO CEO | 3,900 | $6.88 | 172,094 (Direct) | View |
| 2020-03-30 Exercise | 2020-03-31 6:00 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO CEO | 3,900 | $6.88 | 172,094 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 4:16 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO | 3,500 | $6.88 | 175,994 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 4:16 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO | 3,500 | $6.88 | 175,994 (Direct) | View |
| 2020-03-09 Exercise | 2020-03-11 4:01 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 3,408 | $6.14 | 207,877 (Direct) | View |
| 2020-03-09 Exercise | 2020-03-11 4:01 pm | N/A 2027-04-04 | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 3,408 | $6.14 | 207,877 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:24 pm | N/A 2030-02-13 | RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer | 80,000 | $17.87 | 80,000 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:24 pm | N/A 2030-02-13 | RHYTHM PHARMACEUTICALS Inc | RYTM | Kelner Simon Chief Human Resources Officer | 60,000 | $17.87 | 60,000 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:23 pm | N/A 2030-02-13 | RHYTHM PHARMACEUTICALS Inc | RYTM | Stewart Murray Chief Medical Officer | 88,000 | $17.87 | 88,000 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:23 pm | N/A 2030-02-13 | RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO | 82,000 | $17.87 | 82,000 (Direct) | View |
| 2020-02-10 Exercise | 2020-02-12 4:00 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 6,816 | $6.14 | 211,286 (Direct) | View |
| 2020-02-10 Exercise | 2020-02-12 4:00 pm | N/A 2027-04-04 | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 6,816 | $6.14 | 211,286 (Direct) | View |
| 2020-01-28 Exercise | 2020-01-29 4:00 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO | 6,250 | $6.88 | 179,494 (Direct) | View |
| 2020-01-28 Exercise | 2020-01-29 4:00 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO | 6,250 | $6.88 | 179,494 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 4:01 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 33,072 | $4.59 | 84,208 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 4:01 pm | N/A 2025-11-16 | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 33,072 | $4.59 | 84,208 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 4:02 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer | 35,181 | $6.88 | 29,068 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 4:02 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer | 35,181 | $6.88 | 29,068 (Direct) | View |
| 2019-08-12 Exercise | 2019-08-13 4:04 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer | 14,534 | $6.88 | 172,676 (Direct) | View |
| 2019-08-12 Exercise | 2019-08-13 4:04 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer | 14,534 | $6.88 | 172,676 (Direct) | View |
| 2019-07-30 Option Award | 2019-08-01 4:06 pm | N/A 2029-07-29 | RHYTHM PHARMACEUTICALS Inc | RYTM | Arbuckle Stuart A Director | 30,000 | $19.05 | 30,000 (Direct) | View |
| 2019-07-16 Exercise | 2019-07-17 4:11 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 7,500 | $4.59 | 117,280 (Direct) | View |
| 2019-07-16 Exercise | 2019-07-17 4:11 pm | N/A 2025-11-16 | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 7,500 | $4.59 | 117,280 (Direct) | View |
| 2019-07-11 Exercise | 2019-07-15 4:01 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO | 10,000 | $6.88 | 185,744 (Direct) | View |
| 2019-07-11 Exercise | 2019-07-15 4:01 pm | N/A 2027-08-08 | RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO | 10,000 | $6.88 | 185,744 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-21 4:17 pm | N/A 2029-06-18 | RHYTHM PHARMACEUTICALS Inc | RYTM | Mathers Edward T Director | 15,000 | $22.93 | 15,000 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-21 4:15 pm | N/A 2029-06-18 | RHYTHM PHARMACEUTICALS Inc | RYTM | GOOD JENNIFER L Director | 30,000 | $22.93 | 30,000 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-21 4:14 pm | N/A 2029-06-18 | RHYTHM PHARMACEUTICALS Inc | RYTM | MCGIRR DAVID W J Director | 15,000 | $22.93 | 15,000 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-21 4:14 pm | N/A 2029-06-18 | RHYTHM PHARMACEUTICALS Inc | RYTM | Meeker David P Director | 15,000 | $22.93 | 15,000 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-21 4:13 pm | N/A 2029-06-18 | RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director | 15,000 | $22.93 | 15,000 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-21 4:13 pm | N/A 2029-06-18 | RHYTHM PHARMACEUTICALS Inc | RYTM | JEAN CHRISTOPHE Director | 15,000 | $22.93 | 15,000 (Direct) | View |
| 2019-05-30 Exercise | 2019-06-03 4:00 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 5,000 | $4.59 | 42,339 (Direct) | View |
| 2019-05-30 Exercise | 2019-06-03 4:00 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 5,000 | $4.59 | 42,339 (Direct) | View |
| 2019-05-30 Exercise | 2019-06-03 4:00 pm | N/A 2025-11-16 | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 5,000 | $4.59 | 42,339 (Direct) | View |
| 2019-05-30 Exercise | 2019-06-03 4:00 pm | N/A 2025-11-16 | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 5,000 | $4.59 | 42,339 (Direct) | View |
| 2019-05-28 Exercise | 2019-05-30 4:01 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 9,860 | $4.59 | 42,339 (Direct) | View |
| 2019-05-28 Exercise | 2019-05-30 4:01 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 140 | $6.14 | 42,339 (Direct) | View |
| 2019-05-28 Exercise | 2019-05-30 4:01 pm | N/A N/A | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 5,000 | $4.59 | 42,339 (Direct) | View |
| 2019-05-28 Exercise | 2019-05-30 4:01 pm | N/A 2025-11-16 | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 9,860 | $4.59 | 42,339 (Direct) | View |
| 2019-05-28 Exercise | 2019-05-30 4:01 pm | N/A 2027-04-04 | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 140 | $6.14 | 42,339 (Direct) | View |
| 2019-05-28 Exercise | 2019-05-30 4:01 pm | N/A 2025-11-16 | RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 5,000 | $4.59 | 42,339 (Direct) | View |
| 2019-02-13 Option Award | 2019-02-15 4:10 pm | N/A 2029-02-12 | RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO | 70,000 | $29.78 | 70,000 (Direct) | View |
| 2019-02-13 Option Award | 2019-02-15 4:09 pm | N/A 2029-02-12 | RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO | 225,000 | $29.78 | 540,986 (Direct) | View |
| 2019-02-13 Option Award | 2019-02-15 4:09 pm | N/A 2029-02-12 | RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer | 70,000 | $29.78 | 70,000 (Direct) | View |